Receptor
From Proteopedia
(Difference between revisions)
Line 10: | Line 10: | ||
**[[Journal:JBSD:16|The extracellular subunit interface of the 5-HT3 receptors: a computational alanine scanning mutagenesis study]]<ref>DOI 10.1080/07391102.2012.680029</ref> | **[[Journal:JBSD:16|The extracellular subunit interface of the 5-HT3 receptors: a computational alanine scanning mutagenesis study]]<ref>DOI 10.1080/07391102.2012.680029</ref> | ||
**[[5-hydroxytryptamine receptor#5-HT3 receptor antagonists]] | **[[5-hydroxytryptamine receptor#5-HT3 receptor antagonists]] | ||
+ | |||
+ | === The extracellular subunit interface of the 5-HT3 receptors: a computational alanine scanning mutagenesis study<ref>DOI 10.1080/07391102.2012.680029</ref> === | ||
+ | |||
+ | The serotonin type-3 receptor (5-HT3-R) is a cation selective transmembrane protein channel that belongs to the Cys–loop Ligand-Gated Ion Channel (LGIC) superfamily (http://www.ebi.ac.uk/compneur-srv/LGICdb/LGICdb.php), which also includes receptors for nicotinic acetylcholine (<scene name='Journal:JBSD:16/Cv/2'>nAChR</scene>, PDB code [[2bg9]]), γ-aminobutyric acid and glycine. 5-HT3-R is involved in signal transmission in the central and peripheral nervous system and its malfunctioning leads to neurodegenerative and psychiatric diseases, therefore it is an important target for drug design research. A few drugs active against 5-HT3-R are already on the market, such as, for example, palonosetron (http://en.wikipedia.org/wiki/Palonosetron) and granisetron (http://en.wikipedia.org/wiki/Granisetron). | ||
+ | The 5-HT3R is made of five monomers assembled in a <scene name='Journal:JBSD:16/Cv/4'>pseudo-symmetric pentameric shape</scene> to form an ion channel permeable to small ions (Na+, K+); each subunit contains three domains: an <scene name='Journal:JBSD:16/Cv/3'>intracellular portion, a transmembrane domain and an extracellular region</scene> (shown on the example of nAChR, [[2bg9]]). To date, five different 5-HT3-R subunits have been identified, the 5-HT3 A, B, C, D and E; however, only subunits A and B have been extensively characterised experimentally. The <scene name='Journal:JBSD:16/Cv/6'>ligand binding site</scene> of nAChR is located at the extracellular region, at the interface between two monomers (α-γ and α-δ; 2 identical α monomers, chains A and D, are colored in same color - lavender), called the principal and the complementary subunits. | ||
+ | The 3D structure of 5-HT3-R has not been experimentally solved yet; however, it has been obtained computationally by means of homology modelling techniques. (http://salilab.org/modeller/) | ||
+ | Thus, the <scene name='Journal:JBSD:16/Cv/7'>extracellular region of the 5HT3 subunits A and B</scene> are modelled by homology with the 3D structure of the nAChR subunit A ([[2bg9]]-A) and are used to assemble receptor structures as pseudo-symmetric pentamers made either of <scene name='Journal:JBSD:16/Cv/9'>five identical subunits A (homomeric 5-HT3A-R)</scene> or of <scene name='Journal:JBSD:16/Cv/10'>both subunits A and B (heteromeric 5-HT3A/B-R in the BBABA arrangement)</scene> in a still debated arrangement.<ref>PMID:20724042 </ref> Subunits <font color='magenta'><b>A</b></font> and <font color='red'><b>B</b></font> are colored in <font color='magenta'><b>magenta</b></font> and <font color='red'><b>red</b></font>, respectively. | ||
+ | A complete characterization of the extracellular moiety of the <scene name='Journal:JBSD:16/Cv/15'>dimer interface of the 5-HT3-R</scene> (AA dimer is shown, <span style="color:cyan;background-color:black;font-weight:bold;">principal subunit is colored in cyan</span> and <font color='blue'><b>complementary is in blue</b></font>, is obtained by the Computational Alanine Scanning Mutagenesis (CASM) approach <ref>PMID:17195156</ref>, which simulates the substitution, one by one, of all the amino acid residues at the subunit-subunit interfaces with an Ala, thus to assess the interface binding contribution of single residue side-chains. The <scene name='Journal:JBSD:16/Cv/16'>most relevant residues for interface stabilization</scene> are classified as “hot spots” that stabilize the interface by more than 4 kcal/mol and “warm spots” that contribute to interface stabilization by more than 2 kcal/mol. <scene name='Journal:JBSD:16/Cv/17'>Click here to see also the interface of complementary subunit.</scene> Interface residues are shown in spacefill representation, <font color='red'><b>hot spot residues are colored in red</b></font> and <span style="color:orange;background-color:black;font-weight:bold;">warm spots residues are are in orange</span>. | ||
+ | From this analysis the <scene name='Journal:JBSD:16/Cv/18'>important aromatic cluster</scene> located at the interface core and formed by residues W178 (principal subunit), Y68, Y83, W85 and Y148 (complementary subunit) is highlighted.<ref>DOI:10.1080/07391102.2012.680029</ref> In addition, two important groups of interface residues are probably involved in the coupling of <scene name='Journal:JBSD:16/Cv1/6'>agonist</scene> and <scene name='Journal:JBSD:16/Cv1/10'>antagonist</scene> binding to channel activation/inactivation: W116-H180-L179-W178-E124-F125 (principal subunit) and Y136-Y138-Y148-W85-(P150) (complementary subunit), where W178 and Y148 appear to be critical residues for the binding/activation mechanism. Finally, the <scene name='Journal:JBSD:16/Cv1/8'>comparison of the AA interface with the BB interface</scene> (<span style="color:cyan;background-color:black;font-weight:bold;">principal subunit of AA is colored in cyan</span>, <font color='darkmagenta'><b>principal subunit BB is colored in darkmagenta</b></font>, <font color='blue'><b>complementary subunit AA is in blue</b></font> and <font color='magenta'><b>complementary subunit BB is in magenta</b></font>) shows differences which could explain the reasons why the homopentamer 5-HT3B-R, if expressed, is not functional (see also image below).<ref>DOI: 10.1039/C2CP41028A</ref> | ||
+ | |||
+ | [[Image:Fig 7.png|left|400px|thumb|]] | ||
**[[Nicotinic Acetylcholine Receptor|Nicotinic Acetylcholine Receptors in general]] | **[[Nicotinic Acetylcholine Receptor|Nicotinic Acetylcholine Receptors in general]] | ||
**[[Alpha-bungarotoxin]] is a nicotinic cholinergic antagonist that is found within the venom of ''Bungarus multicinctus'', a South-asian snake belonging to a group commonly known as kraits. | **[[Alpha-bungarotoxin]] is a nicotinic cholinergic antagonist that is found within the venom of ''Bungarus multicinctus'', a South-asian snake belonging to a group commonly known as kraits. |
Revision as of 13:35, 13 April 2021
|
References
- ↑ De Rienzo F, Moura Barbosa AJ, Perez MA, Fernandes PA, Ramos MJ, Menziani MC. The extracellular subunit interface of the 5-HT(3) receptors: a computational alanine scanning mutagenesis study. J Biomol Struct Dyn. 2012 Jul;30(3):280-98. Epub 2012 Jun 12. PMID:22694192 doi:10.1080/07391102.2012.680029
- ↑ De Rienzo F, Moura Barbosa AJ, Perez MA, Fernandes PA, Ramos MJ, Menziani MC. The extracellular subunit interface of the 5-HT(3) receptors: a computational alanine scanning mutagenesis study. J Biomol Struct Dyn. 2012 Jul;30(3):280-98. Epub 2012 Jun 12. PMID:22694192 doi:10.1080/07391102.2012.680029
- ↑ Moura Barbosa AJ, De Rienzo F, Ramos MJ, Menziani MC. Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors. Eur J Med Chem. 2010 Nov;45(11):4746-60. Epub 2010 Jul 27. PMID:20724042 doi:10.1016/j.ejmech.2010.07.039
- ↑ Moreira IS, Fernandes PA, Ramos MJ. Computational alanine scanning mutagenesis--an improved methodological approach. J Comput Chem. 2007 Feb;28(3):644-54. PMID:17195156 doi:10.1002/jcc.20566
- ↑ De Rienzo F, Moura Barbosa AJ, Perez MA, Fernandes PA, Ramos MJ, Menziani MC. The extracellular subunit interface of the 5-HT(3) receptors: a computational alanine scanning mutagenesis study. J Biomol Struct Dyn. 2012 Jul;30(3):280-98. Epub 2012 Jun 12. PMID:22694192 doi:10.1080/07391102.2012.680029
- ↑ De Rienzo F, Del Cadia M, Menziani MC. A first step towards the understanding of the 5-HT(3) receptor subunit heterogeneity from a computational point of view. Phys Chem Chem Phys. 2012 Sep 28;14(36):12625-36. Epub 2012 Aug 9. PMID:22880201 doi:10.1039/c2cp41028a
- ↑ Segaliny AI, Tellez-Gabriel M, Heymann MF, Heymann D. Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers. J Bone Oncol. 2015 Jan 23;4(1):1-12. doi: 10.1016/j.jbo.2015.01.001. eCollection , 2015 Mar. PMID:26579483 doi:http://dx.doi.org/10.1016/j.jbo.2015.01.001
- ↑ Li MJ, Greenblatt HM, Dym O, Albeck S, Pais A, Gunanathan C, Milstein D, Degani H, Sussman JL. Structure of estradiol metal chelate and estrogen receptor complex: The basis for designing a new class of selective estrogen receptor modulators. J Med Chem. 2011 Apr 7. PMID:21473635 doi:10.1021/jm200192y